These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20987614)

  • 1. [Investigations on the antitoxin content of the anti-gigantic serum].
    BULLER SOUTO A; SCHWINDT FURLANETTO R
    Rev Inst Adolfo Lutz; 1945 Dec; 5():353-74. PubMed ID: 20987614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Notes on the titration of antiperfringens a sera].
    GUILLAUMIE M; KREGUER A; FABRE M
    Ann Inst Pasteur (Paris); 1946; 72(7-8):651-6. PubMed ID: 20238820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of synthomycin and levomycin alone or in combination with anti-gangrene serum in experimental gas infection produced by an association of microorganisms].
    SOLOV'EV SV; MATVEEV KI
    Eksp Khirurgiia; 1960; 5():62. PubMed ID: 13832691
    [No Abstract]   [Full Text] [Related]  

  • 4. A STUDY OF THE COMPETITION OF LECITHIN AND ANTITOXIN FOR CL. WELCHII LECITHINASE.
    Zamecnik PC; Lipmann F
    J Exp Med; 1947 Mar; 85(4):395-403. PubMed ID: 19871624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the production of gas gangrene serum in general and of polyvalent gas gangrene aphylacto-serum of the horse especially using the simultaneous immunization method with the 4 known gas gangrene types in uno].
    Becker M
    Arch Exp Veterinarmed; 1967; 21(2):519-46. PubMed ID: 4302817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complex treatment of gas gangrene. V. Effect of polyvalent anti-gangrene serum on tetravalent infection of the guinea pig, produced according to a personal experimental model].
    Bittner J; Ardeleanu J; Cherciu I
    Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):45-57. PubMed ID: 5096861
    [No Abstract]   [Full Text] [Related]  

  • 7. MODERN TRENDS IN THE TREATMENT OF GAS-GANGRENE.
    SANDERS GB
    J Ky Med Assoc; 1965 Jan; 63():21-4. PubMed ID: 14221923
    [No Abstract]   [Full Text] [Related]  

  • 8. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN).
    EVANS DG; PERKINS FT
    Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-gangrene serums. Persistence of anti-septicum and anti-oedematiens immunity after the arrest of corresponding immunization].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    Rev Immunol Ther Antimicrob; 1960; 24():581-605. PubMed ID: 13709613
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative evaluation of the medicinal and prophylactic properties of the antitetanic and antigangrenous sera obtained from cattle and horses.
    SHCHEPETOV FN
    Zh Mikrobiol Epidemiol Immunobiol; 1945; (7-8):29-32. PubMed ID: 20984540
    [No Abstract]   [Full Text] [Related]  

  • 11. [SORPTION OF ANTITOXIC ANTIGANGRENE SERUM WITH HUMAN ERYTHROCYTES].
    SINADSKII NE
    Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():121-3. PubMed ID: 14077123
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental gas gangrene: the effect of antiserum on the growth of Clostridium welchii type A.
    BULLEN JJ; CUSHNIE GH
    J Pathol Bacteriol; 1962 Jul; 84():177-92. PubMed ID: 13874612
    [No Abstract]   [Full Text] [Related]  

  • 13. Gas gangrene infection: combined treatment including 3,432,000 international units of polyvalent gas gangrene antitoxin.
    Hamsa WR; Burney DW
    Nebr State Med J; 1966 Mar; 51(3):85-9. PubMed ID: 4221920
    [No Abstract]   [Full Text] [Related]  

  • 14. GAS GANGRENE INFECTION, ANTITOXIN, AND SERUM NEURITIS.
    CROCKER LG; CUNNINGHAM M
    Arch Intern Med; 1965 Feb; 115():173-5. PubMed ID: 14331998
    [No Abstract]   [Full Text] [Related]  

  • 15. ASSAY OF POTENCY OF THE PROPOSED FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS).
    PRIGGE R; MICKE H; KRUEGER J
    Bull World Health Organ; 1963; 29(6):737-43. PubMed ID: 14107746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of antitoxin in the tissues of animals immunized with Cl. welchii toxin.
    KEPPIE J; MACFARLANE MG
    Br J Exp Pathol; 1948 Oct; 29(5):458-66. PubMed ID: 18108413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intraosseous method of administering specific sera for the prevention and treatment of gas gangrene].
    Mitskevich AI; Shtefan EE
    Klin Khir (1962); 1970 Mar; 3():53-5. PubMed ID: 5451789
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of cell cultures for titration of gangrene toxins and gangrene antisera].
    Zakharova NS; Kamzolkina NB
    Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):135-6. PubMed ID: 5616795
    [No Abstract]   [Full Text] [Related]  

  • 19. [The significance of aerobe mixed infection in gas gangrene. II. The behavior of the Welch-Fraenkel gas gangrene bacillus in aerobic mixed infections (in vivo)].
    Tarbiat S; Grün L
    Zentralbl Chir; 1967 Nov; 92(45):2805-10. PubMed ID: 4298966
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gas gangrene therapy and hyperbaric oxygenation].
    Schmauss AK; Bahrmann E; Fabian W
    Zentralbl Chir; 1973 Jun; 98(25):912-25. PubMed ID: 4741472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.